DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Donson AM, Addo-Yobo SO, Handler MH. et al.
MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
Pediatr Blood Cancer 2007; 48: 403-407
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.